Mega Lifesciences Public Company Limited (BK:MEGA-R) — Market Cap & Net Worth
Market Cap & Net Worth: Mega Lifesciences Public Company Limited (MEGA-R)
Mega Lifesciences Public Company Limited (BK:MEGA-R) has a market capitalization of $869.61 Million (฿27.90 Billion) as of September 24, 2026. Listed on the BK stock exchange, this Thailand-based company holds position #9646 globally and #91 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Mega Lifesciences Public Company Limited's stock price ฿32.00 by its total outstanding shares 871869508 (871.87 Million). Also see Mega Lifesciences Public Company Limited (MEGA-R) total assets for a full breakdown of the balance sheet.
Mega Lifesciences Public Company Limited Market Cap History: 2020 to 2025
Mega Lifesciences Public Company Limited's market capitalization history from 2020 to 2025. Data shows change from $971.52 Million to $869.61 Million (-2.40% CAGR). Also see cash flow conversion of Mega Lifesciences Public Company Limited for how efficiently the company converts equity into cash flow.
Mega Lifesciences Public Company Limited Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Mega Lifesciences Public Company Limited's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check Mega Lifesciences Public Company Limited stock price for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
0.06x
Mega Lifesciences Public Company Limited's market cap is 0.06 times its annual revenue
Latest Price to Earnings (P/E) Ratio
0.44x
Mega Lifesciences Public Company Limited's market cap is 0.44 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2020 | $971.52 Million | $12.59 Billion | $1.39 Billion | 0.08x | 0.70x |
| 2021 | $937.55 Million | $14.14 Billion | $1.95 Billion | 0.07x | 0.48x |
| 2022 | $1.28 Billion | $15.69 Billion | $2.24 Billion | 0.08x | 0.57x |
| 2023 | $1.07 Billion | $15.68 Billion | $1.99 Billion | 0.07x | 0.54x |
| 2024 | $888.08 Million | $15.34 Billion | $2.01 Billion | 0.06x | 0.44x |
Competitor Companies of MEGA-R by Market Capitalization
Companies near Mega Lifesciences Public Company Limited in the global market cap rankings as of September 24, 2026. Review Mega Lifesciences Public Company Limited (MEGA-R) tangible equity ratio to assess the quality of the company's equity after excluding intangible assets.
Key companies related to Mega Lifesciences Public Company Limited by market ranking:
- Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #524 globally with a market cap of $52.60 Billion USD.
- GALDERMA GROUP AG (NYSE:GALDY): Ranked #586 globally with a market cap of $46.44 Billion USD.
- Takeda Pharmaceutical Company Limited (F:TKDA): Ranked #638 globally with a market cap of $43.60 Billion USD ( €37.29 Billion EUR).
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #651 globally with a market cap of $42.68 Billion USD ( CN¥291.65 Billion CNY).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #524 | Takeda Pharmaceutical Co Ltd ADR | NYSE:TAK | $52.60 Billion | $16.65 |
| #586 | GALDERMA GROUP AG | NYSE:GALDY | $46.44 Billion | $39.83 |
| #638 | Takeda Pharmaceutical Company Limited | F:TKDA | $43.60 Billion | €16.50 |
| #651 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $42.68 Billion | CN¥45.72 |
Mega Lifesciences Public Company Limited Historical Marketcap From 2020 to 2025
Between 2020 and today, Mega Lifesciences Public Company Limited's market cap moved from $971.52 Million to $ 869.61 Million, with a yearly change of -2.40%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | ฿869.61 Million | -2.08% |
| 2024 | ฿888.08 Million | -16.76% |
| 2023 | ฿1.07 Billion | -16.70% |
| 2022 | ฿1.28 Billion | +36.61% |
| 2021 | ฿937.55 Million | -3.50% |
| 2020 | ฿971.52 Million | -- |
End of Day Market Cap According to Different Sources
On Sep 8th, 2026 the market cap of Mega Lifesciences Public Company Limited was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $869.61 Million USD |
| MoneyControl | $869.61 Million USD |
| MarketWatch | $869.61 Million USD |
| marketcap.company | $869.61 Million USD |
| Reuters | $869.61 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Mega Lifesciences Public Company Limited
Mega Lifesciences Public Company Limited, together with its subsidiaries, manufactures and sells health food supplements, prescription pharmaceutical products, over-the-counter products, herbal products, vitamins, and fast-moving consumer goods in Southeast Asia and Sub-Saharan Africa. The company operates in three segments: Brands, Distribution, and Original Equipment Manufacture (OEM). It provi… Read more